Variable | Incidence | Unadjusted p value | Adjusted p value | Adjusted OR | 95% CI | |
---|---|---|---|---|---|---|

Admission n = 18 (%) | No admit n = 210 (%) | |||||

Incidence, number of patients for which this variable occurred. Unadjusted p value, univariate analysis. Adjusted p value, p value adjusted for all other variables. *Continuous variable so that the OR increases incrementally with each unit increase in variable; †median (SD); Corticosteroids, use of non-inhaled catabolic corticosteroids; IVDU, intravenous drug user. Other abbreviations as in tables 3 and 4. | ||||||

No focus found | 5 (28) | 70 (33) | 0.01 | 0.01 | 0.13 | 0.03 to 0.55 |

Female | 11 (61) | 80 (38) | 0.19 | 0.02 | 5.36 | 1.36 to 21.2 |

Malignancy | 3 (17) | 3 (1.5) | <0.01 | 0.02 | 15.32 | 1.55 to 151.9 |

RR* | 17 (5.0)† | 18 (6.6)† | 0.16 | 0.03 | 1.16 | 1.01 to 1.33 |

Cardiac | 1 (6) | 3 (1.5) | 0.28 | 0.04 | 19.71 | 1.12 to 345.9 |

Chemotherapy | 2 (11) | 1 (0.5) | <0.01 | 0.06 | NA | |

Corticosteroids | 2 (11) | 4 (2) | 0.04 | 0.20 | NA | |

IVDU | 1 (6) | 1 (0.5) | 0.05 | 0.05 | NA |